Occudo Quantitative Strategies LP Takes Position in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Occudo Quantitative Strategies LP bought a new stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 22,464 shares of the company's stock, valued at approximately $455,000.

Other hedge funds have also recently made changes to their positions in the company. Barclays PLC bought a new stake in shares of Guardian Pharmacy Services during the third quarter valued at approximately $311,000. Investment Research & Advisory Group Inc. bought a new stake in shares of Guardian Pharmacy Services during the fourth quarter valued at approximately $34,000. R Squared Ltd bought a new stake in shares of Guardian Pharmacy Services during the fourth quarter valued at approximately $30,000. Calamos Advisors LLC boosted its position in shares of Guardian Pharmacy Services by 124.7% during the fourth quarter. Calamos Advisors LLC now owns 24,725 shares of the company's stock valued at $501,000 after purchasing an additional 13,720 shares in the last quarter. Finally, Compass Financial Services Inc bought a new stake in shares of Guardian Pharmacy Services during the fourth quarter valued at approximately $58,000.

Analyst Ratings Changes

Separately, Truist Financial lifted their price target on Guardian Pharmacy Services from $24.00 to $25.00 and gave the company a "buy" rating in a research report on Friday, April 11th.

Guardian Pharmacy Services Trading Up 2.9%

Shares of NYSE:GRDN opened at $24.82 on Friday. The stock has a fifty day simple moving average of $22.63 and a two-hundred day simple moving average of $21.74. Guardian Pharmacy Services, Inc. has a 12-month low of $14.16 and a 12-month high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The business had revenue of $329.31 million during the quarter, compared to analyst estimates of $321.21 million. Research analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.